Selected Financial Data
since 2005
Income Statement
Eli Lilly & Co., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenue | Net income (loss) |
|---|---|---|
| Dec 31, 2023 | 34,124,100) | 5,240,400) |
| Dec 31, 2022 | 28,541,400) | 6,244,800) |
| Dec 31, 2021 | 28,318,400) | 5,581,700) |
| Dec 31, 2020 | 24,539,800) | 6,193,700) |
| Dec 31, 2019 | 22,319,500) | 8,318,400) |
| Dec 31, 2018 | 24,555,700) | 3,232,000) |
| Dec 31, 2017 | 22,871,300) | (204,100) |
| Dec 31, 2016 | 21,222,100) | 2,737,600) |
| Dec 31, 2015 | 19,958,700) | 2,408,400) |
| Dec 31, 2014 | 19,615,600) | 2,390,500) |
| Dec 31, 2013 | 23,113,100) | 4,684,800) |
| Dec 31, 2012 | 22,603,400) | 4,088,600) |
| Dec 31, 2011 | 24,286,500) | 4,347,700) |
| Dec 31, 2010 | 23,076,000) | 5,069,500) |
| Dec 31, 2009 | 21,836,000) | 4,328,800) |
| Dec 31, 2008 | 20,378,000) | (2,071,900) |
| Dec 31, 2007 | 18,633,500) | 2,953,000) |
| Dec 31, 2006 | 15,691,000) | 2,662,700) |
| Dec 31, 2005 | 14,645,300) | 1,979,600) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Eli Lilly & Co., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2023 | 25,727,000) | 64,006,300) |
| Dec 31, 2022 | 18,034,500) | 49,489,800) |
| Dec 31, 2021 | 18,452,400) | 48,806,000) |
| Dec 31, 2020 | 17,462,100) | 46,633,100) |
| Dec 31, 2019 | 13,709,600) | 39,286,100) |
| Dec 31, 2018 | 20,549,600) | 43,908,400) |
| Dec 31, 2017 | 19,202,100) | 44,981,000) |
| Dec 31, 2016 | 15,101,400) | 38,805,900) |
| Dec 31, 2015 | 12,573,600) | 35,568,900) |
| Dec 31, 2014 | 12,179,800) | 37,178,200) |
| Dec 31, 2013 | 13,104,700) | 35,248,700) |
| Dec 31, 2012 | 13,038,700) | 34,398,900) |
| Dec 31, 2011 | 14,248,200) | 33,659,800) |
| Dec 31, 2010 | 14,840,000) | 31,001,400) |
| Dec 31, 2009 | 12,486,500) | 27,460,900) |
| Dec 31, 2008 | 12,453,300) | 29,212,600) |
| Dec 31, 2007 | 12,256,900) | 26,787,800) |
| Dec 31, 2006 | 9,694,400) | 21,955,400) |
| Dec 31, 2005 | 10,795,800) | 24,580,800) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Eli Lilly & Co., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Total debt | Total Eli Lilly and Company shareholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2023 | 27,293,200) | 53,142,600) | 25,225,300) | 10,771,900) |
| Dec 31, 2022 | 17,138,200) | 38,714,400) | 16,238,600) | 10,649,800) |
| Dec 31, 2021 | 15,052,700) | 39,651,200) | 16,884,700) | 8,979,200) |
| Dec 31, 2020 | 12,481,600) | 40,807,900) | 16,595,300) | 5,641,600) |
| Dec 31, 2019 | 11,775,200) | 36,587,000) | 15,317,200) | 2,606,900) |
| Dec 31, 2018 | 11,888,100) | 32,999,300) | 12,770,900) | 9,828,700) |
| Dec 31, 2017 | 14,535,900) | 33,313,100) | 13,647,100) | 11,592,200) |
| Dec 31, 2016 | 10,986,600) | 24,725,400) | 10,305,200) | 14,007,700) |
| Dec 31, 2015 | 8,229,600) | 20,978,600) | 7,978,500) | 14,571,300) |
| Dec 31, 2014 | 11,207,500) | 21,790,100) | 8,056,400) | 15,373,200) |
| Dec 31, 2013 | 8,916,600) | 17,608,000) | 5,212,900) | 17,631,400) |
| Dec 31, 2012 | 8,389,500) | 19,625,000) | 5,531,300) | 14,765,200) |
| Dec 31, 2011 | 8,930,900) | 20,124,200) | 6,987,000) | 13,541,700) |
| Dec 31, 2010 | 7,101,400) | 18,588,600) | 6,926,500) | 12,420,300) |
| Dec 31, 2009 | 6,568,100) | 17,935,600) | 6,662,100) | 9,523,700) |
| Dec 31, 2008 | 13,109,700) | 22,474,900) | 10,462,000) | 6,735,300) |
| Dec 31, 2007 | 5,268,300) | 13,123,400) | 5,007,200) | 13,664,400) |
| Dec 31, 2006 | 5,085,500) | 10,974,700) | 3,713,800) | 10,980,700) |
| Dec 31, 2005 | 5,716,300) | 13,788,900) | 6,498,200) | 10,791,900) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Eli Lilly & Co., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by operating activities | Net cash (used for) provided by investing activities | Net cash provided by (used for) financing activities |
|---|---|---|---|
| Dec 31, 2023 | 4,240,100) | (7,152,700) | 3,495,600) |
| Dec 31, 2022 | 7,084,400) | (3,261,600) | (5,406,700) |
| Dec 31, 2021 | 7,260,700) | (2,762,300) | (4,131,300) |
| Dec 31, 2020 | 6,499,600) | (2,258,900) | (3,137,100) |
| Dec 31, 2019 | 4,836,600) | (8,082,900) | (2,324,500) |
| Dec 31, 2018 | 5,524,500) | 1,906,000) | (5,904,900) |
| Dec 31, 2017 | 5,615,600) | (3,783,600) | 142,600) |
| Dec 31, 2016 | 4,851,000) | (3,139,100) | (559,800) |
| Dec 31, 2015 | 2,772,800) | 26,800) | (2,919,200) |
| Dec 31, 2014 | 4,367,100) | (3,909,100) | (75,100) |
| Dec 31, 2013 | 5,735,000) | (2,072,800) | (3,829,300) |
| Dec 31, 2012 | 5,304,800) | (2,832,800) | (4,419,600) |
| Dec 31, 2011 | 7,234,500) | (4,824,400) | (2,369,900) |
| Dec 31, 2010 | 6,856,800) | (3,159,800) | (2,021,900) |
| Dec 31, 2009 | 4,335,500) | 142,800) | (5,533,700) |
| Dec 31, 2008 | 7,295,600) | (7,268,800) | 2,346,000) |
| Dec 31, 2007 | 5,154,500) | (4,328,100) | (844,900) |
| Dec 31, 2006 | 3,975,900) | 608,400) | (4,578,800) |
| Dec 31, 2005 | 1,913,600) | (2,215,900) | (1,880,500) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Eli Lilly & Co., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2023 | 5.82 | 5.80 | 4.69 |
| Dec 31, 2022 | 6.93 | 6.90 | 4.07 |
| Dec 31, 2021 | 6.15 | 6.12 | 3.53 |
| Dec 31, 2020 | 6.82 | 6.79 | 3.07 |
| Dec 31, 2019 | 8.93 | 8.89 | 2.68 |
| Dec 31, 2018 | 3.14 | 3.13 | 2.33 |
| Dec 31, 2017 | -0.19 | -0.19 | 2.12 |
| Dec 31, 2016 | 2.59 | 2.58 | 2.05 |
| Dec 31, 2015 | 2.27 | 2.26 | 2.01 |
| Dec 31, 2014 | 2.23 | 2.23 | 1.97 |
| Dec 31, 2013 | 4.33 | 4.32 | 1.96 |
| Dec 31, 2012 | 3.67 | 3.66 | 1.96 |
| Dec 31, 2011 | 3.90 | 3.90 | 1.96 |
| Dec 31, 2010 | 4.58 | 4.58 | 1.96 |
| Dec 31, 2009 | 3.94 | 3.94 | 1.96 |
| Dec 31, 2008 | -1.89 | -1.89 | 1.90 |
| Dec 31, 2007 | 2.71 | 2.71 | 1.75 |
| Dec 31, 2006 | 2.45 | 2.45 | 1.63 |
| Dec 31, 2005 | 1.82 | 1.81 | 1.54 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.